What is Selank?
Selank is an unregulated synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) marketed as a dietary supplement that lacks FDA approval for any medical indication and should not be recommended for clinical use due to absence of required safety and efficacy data.
Regulatory Status and Critical Context
Selank falls into the category of dietary supplements that are not subject to FDA premarket approval requirements 1. Unlike FDA-approved medications, dietary supplements:
- Require no proof of efficacy before marketing
- Require no proof of safety before marketing
- Have no premarket notification requirements
- Cannot make disease treatment claims 1
This regulatory gap means Selank has never undergone the rigorous testing required for approved medications, and its quality, purity, and consistency cannot be guaranteed 1.
Composition and Claimed Mechanism
Selank is described in research literature as a synthetic analog of tuftsin, an endogenous tetrapeptide 2, 3. The proposed mechanisms from preclinical studies include:
- Modulation of GABAergic neurotransmission 4
- Inhibition of enkephalin-degrading enzymes 2
- Effects on brain-derived neurotrophic factor (BDNF) 5
- Modulation of cytokine levels 6
However, these are exclusively animal studies with no validated human clinical data.
Evidence Base: Critical Limitations
All available evidence consists of:
- Rat and mouse studies only 2, 3, 7, 4, 5, 6
- Small sample sizes
- No Phase I, II, or III human clinical trials
- No FDA review of safety or efficacy
- Publications primarily in non-mainstream journals
The research studies show effects on anxiety-like behaviors in rodents 3, morphine withdrawal symptoms 7, and memory in alcohol-exposed rats 5, but these findings cannot be extrapolated to human use.
Safety Profile: Unknown
There are no systematic human safety studies for Selank. The absence of required toxicology studies, drug interaction studies, and long-term safety monitoring means:
- Potential for contamination or adulteration 1
- Unknown drug-drug interactions
- Unknown effects in special populations (pregnancy, renal/hepatic impairment)
- No established safe dosing range in humans
Clinical Recommendation
Do not recommend Selank to patients. The complete absence of human clinical trials, lack of FDA oversight, and potential for manufacturing inconsistencies make this an inappropriate choice when FDA-approved anxiolytics and cognitive enhancers with established safety profiles are available 1.
If Patients Are Using Selank:
- Document use carefully in the medical record
- Counsel on regulatory differences between supplements and FDA-approved drugs 1
- Screen for adverse effects and drug interactions
- Recommend transition to evidence-based therapies with known safety profiles
- Monitor for contamination-related toxicity, particularly nephrotoxicity 1
Key Pitfall to Avoid:
Patients often assume dietary supplements are safe because they are commercially available. Explicitly explain that supplements do not require proof of safety or efficacy before marketing 1, and that Selank specifically has never been tested in humans under controlled conditions.